📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Engineering and stable production of recombinant IgE for cancer immunotherapy and AllergoOncology. (2018)

First Author: Crescioli S

Attributed to: Preclinical efficacy of an antibody of the IgE class against a melanoma-associated antigen funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.jaci.2017.12.986

PubMed Identifier: 29360527

Publication URI: http://europepmc.org/abstract/MED/29360527

Type: Journal Article/Review

Volume: 141

Parent Publication: The Journal of allergy and clinical immunology

Issue: 4

ISSN: 0091-6749